← Leaderboards
Evelyn J Fisher
Virginia Commonwealth University
$3,611,956
Attributed
$3,611,956
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,611,956 · 2
By mechanism
U01$3,592,701 · 1
M01$19,255 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- John E Nestler$6,116,076
- John D Roberts$6,720,279
- Harry D Bear$5,428,734
- Karen S Ingersoll$10,539,581
- Wally R Smith$9,055,907
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationClinical ResearchDrug Screening /EvaluationAids TherapyOpportunistic InfectionsAidsPrognosisCommunity Health ServicesTherapy ComplianceCooperative StudyAntiaids AgentChemopreventionAids /Hiv DiagnosisLongitudinal Human StudyVirus LoadBlood Cell CountBlood ChemistryDosageHelper T LymphocyteHiv InfectionsImmunotherapyInterleukin 2Patient Oriented Research
Grant awards (7)
Subcutaneous Recombinant IL-2 in HIV1 infected Patients$19,255
M01 · FY2004 · RR
RICHMOND AIDS CONSORTIUM 'CPCRA'$949,819
U01 · FY2003 · AI
RICHMOND AIDS CONSORTIUM 'CPCRA'$922,563
U01 · FY2002 · AI
RICHMOND AIDS CONSORTIUM 'CPCRA'$641,427
U01 · FY2001 · AI
RICHMOND AIDS CONSORTIUM 'CPCRA'$874,999
U01 · FY2000 · AI
RICHMOND AIDS CONSORTIUM$203,893
U01 · FY2000 · AI
PHASE II TRIAL OF RECOMBINANT IL 2 IN HIV INFECTION$0
M01 · FY2000 · RR